Featured Investments

VIDEO: Open Orphan’s Cathal Friel on firm’s ambitious plans in the coronavirus vaccination space

13 May 2020 | by: Patricia Miller

In the video below, provided by piworld, Cathal Friel, executive director of Open Orphan (LSE:ORPH) give a presentation to members of ShareSoc at the organisation’s latest Growth Company webinar.

Among other subjects, Friel runs through Open Orphan’s word-first coronavirus challenge model, its subsidiary hVIVO, its vaccine and pharmaceutical portfolio, and its genomic data capturing capabilities.Open Orphan is a European-focussed, rare and orphan drug consulting services platform with four key focuses: European clinical research; orphan drug services; a Virtual Rep and Data Access platform; and a Health Data Platform to partner with Patient Advocacy Groups.

piworld provides content for investors, by investors.

The organisation aims to help private investors get closer to companies and their management and – in turn – make more informed investment decisions.

Videos include:

•             Company results presentations

•             Management interviews

•             Company visits

•             Enlightened educational investor videos with investors, opinion formers, and industry leaders

Valuethemarkets.com, Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

  • Digitonic Ltd, the owner of ValueTheMarkets.com, does not hold a position or positions in the stock(s) and/or financial instrument(s) mentioned in the above article.
  • Digitonic Ltd, the owner of ValueTheMarkets.com, has been paid for the production this piece by the company or companies mentioned above.

More News & Analysis